R. Marquez

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)

G. Thomas, V. Mathur, B. R. Tammelin, 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

A clinical trial with halofantrine on patients with falciparum malaria in Colombia.

V. Navaratnam, E. Boudreau, R. Marquez, 1996, Bulletin of the World Health Organization.